Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

elderly patient and doctor

High-risk prostate cancer patients benefit from shortened course of radiation therapy

At the annual ASTRO meeting, experts shared that not only did the shortened protocol shave weeks off of the scheduled treatment plan, it also did not come at the expense of increased toxicity. 

October 28, 2022
lung CT

CRC patients with these clinical characteristics need more frequent post-op chest imaging

These patients are at greatest risk of developing lung metastases within three months of surgery.

October 17, 2022

What is the radiologist's role in variations of prostate cancer detection?

Prior studies have focused on radiologist performance rather than patient outcomes, leaving the topic of variable diagnoses and what factors impact them—race, ethnicity, age, biopsy type, etc.—open for debate. 

October 17, 2022

PET/CT findings predict post-treatment, radiation-induced hypothyroidism

Radiation-induced hypothyroidism is common yet underdiagnosed, potentially owing to a lack of follow-up consensus in patients treated with radiation therapy for head and neck cancers.

October 13, 2022

Radiologists are overlooking signs of pancreatic cancer on imaging more and more, new study indicates

The research revealed that 7.7% of patients screened for pancreatic cancer had their tumors missed on initial imaging exams but were diagnosed with cancer between three and 18 months later.  

October 11, 2022
Prostate Cancer

Prostate cancer detection boosted with computer assistance

The addition of computer-aided diagnostic generated MRI series could help radiologists identify clinically significant prostate cancer more frequently. 

October 10, 2022
An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence. 

Prostate cancer patients who undergo surveillance MRI in lieu of yearly biopsy not at increased risk

Results of the new work indicate that risks are not exacerbated when imaging is the chosen method of surveillance up until the three-year mark, suggesting that patients can safely forego invasive biopsy for a limited period. 

October 7, 2022

Current LDCT eligibility criteria leave women and minorities behind

Compared to USPSTF 2013,  modified eligibility criteria could increase cancer detection by 37%.

October 5, 2022